Order for whole blood glucose (WBG) instrumentation and testing kits - october 01, 2024 through september 30, 2025

Ended Awarded Last action

Contract number
36C25625N0164
Awardee
Awarding agency
Obligated
$15,052

Award facts

Contract value 100% obligated
$15,051.92 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Increase modification - whole blood glucose (WBG) instrumentation and testing kits - october 01, 2024 through september 30, 2025 $4,380
Original award $10,672

About this award

Roche Diagnostics Corporation received a $15,051.92 firm fixed-price call order from Veterans Integrated Service Network 16 for whole blood glucose instrumentation and testing kits, effective October 1, 2024 through September 30, 2025. This contract is issued as a child order under the parent In Vitro Diagnostics, Reagents, Test (FSS-65-VII) General Services Administration Schedule and was awarded without set-aside designation. The award supports point-of-care glucose testing capabilities for the Department of Veterans Affairs healthcare system, with performance based in Castleton, Indiana.

As a leading provider of diagnostic solutions to federal healthcare agencies, Roche Diagnostics maintains an extensive contracting portfolio across multiple Veterans Integrated Service Networks and the Defense Health Agency. The company supplies comprehensive laboratory equipment, analyzers, reagents, and associated medical products spanning molecular diagnostics, clinical chemistry, immunochemistry, and point-of-care testing. This specific order for glucose instrumentation and testing kits represents a routine replenishment of consumables and equipment needed to support routine glucose monitoring services within the Veterans Health Administration network. The award reflects sustained federal demand for Roche's diagnostic capabilities and aligns with the company's established role as a primary supplier of advanced diagnostic technologies to military, veterans, and civilian healthcare systems.

Quick answers

Who was awarded contract 36C25625N0164?

36C25625N0164 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2024.

How much is contract 36C25625N0164 worth?

The government has obligated $15,052 on 36C25625N0164.

Is contract 36C25625N0164 an order under another contract?

Yes. 36C25625N0164 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C25625N0164 competed?

The extent of competition for 36C25625N0164 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award